Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;54(1):77-9.
doi: 10.4103/0019-5154.48996.

Intravenous immunoglobulin in dermatology

Affiliations

Intravenous immunoglobulin in dermatology

Sandipan Dhar. Indian J Dermatol. 2009.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Similar articles

Cited by

References

    1. Buckley RH, Schiff RI. The use of intravenous immunoglobulin in immunodeficiency diseases. N Engl J Med. 1991;325:110–7. - PubMed
    1. Colsky AS. Intravenous immunoglobulin in autoimmune and inflammatory dermatoses: A review of proposed mechanisms of action and therapeutic applications. Dermatol Clin. 2000;18:447–57. - PubMed
    1. Fernandez AP, Kerdel FA. The use of i.v. IG therapy in dermatology. Dermatol Ther. 2007;20:288–305. - PubMed
    1. Jolles S, Hughes J, Whittaker S. Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol. 1998;134:80–6. - PubMed
    1. Dahl MV, Bridges AG. Intravenous immunoglobulin: Fighting antibodies with antibodies. J Am Acad Dermatol. 2001;45:775–83. - PubMed